Phase 1 submissions closed on April 28, and the Neuromod Prize received 45 concept papers from independent teams, small companies, universities, and medical centers. Teams proposed neuromodulation therapies with a wide range of target organ functions — including in the bladder, heart, lungs, and stomach.

The Phase 1 evaluation process will begin with review panelists evaluating solutions based on the Phase 1 selection criteria. Following this review, the judging panel will select up to eight teams to receive a share of the Phase 1 prize pool (up to $800,000). Phase 1 winners will be announced this summer.

Thank you to our review panel for contributing their knowledge and time:

  • Andrei Pakhomov, Ph.D. Research Professor, Old Dominion University
  • Andrew Cornwell, Ph.D. Associate Director of the Case-Coulter Translational Research Partnership, Case Western Reserve University
  • Antonino Cassara, Ph.D. Neurostimulation Project Leader, IT’IS Foundation
  • Cindy Chestek, Ph.D. Associate Chair for Research in Biomedical Engineering, University of Michigan
  • Daryl Kipke, Ph.D. CEO and Managing Director, NeuroNexus
  • David Linden, Ph.D. Professor of Neuroscience, Johns Hopkins University
  • Douglas Weber, Ph.D. Professor, Carnegie Mellon University
  • Erika Ross, Ph.D. Director of R&D Applied Research, Abbott Neuromodulation
  • Graham Creasey, FRCSEd, Emeritus Faculty, Stanford University
  • Heike Muenzberg-Gruening, Ph.D. Professor, Louisiana State University
  • James Fallon, Ph.D. CTO and Head of Research Operations, Bionics Institute
  • Jeffrey Ardell, Ph.D. Professor-in-Residence, University of California, Los Angeles 
  • Jessy Dorn, Ph.D. Vice President of Clinical and Scientific Affairs, Second Sight
  • Jeyakumar Subbaroyan, Ph.D. Vice President of Clinical Affairs & Research, Nyxaoh
  • Kent Leyde, CEO, Cadence Neuroscience
  • Jimmy Harris, Ph.D. Director of Science and Technology, Presidio Medical
  • Kristen-Smith Edwards, Ph.D. Postdoctoral Research Fellow, University of Pittsburgh
  • Laurent Gautron, Ph.D. Assistant Professor, UT Southwestern Medical Center
  • Natalia Biscola, Ph.D. Postdoctoral Fellow, Icahn School of Medicine at Mount Sinai
  • Nicole Thompson, Research Assistant, University College London
  • Pierre Mourad, Ph.D. Professor, University of Washington, Bothell
  • Robert Greenberg, M.D., Ph.D. Chairman and CEO, Alfred Mann Foundation
  • Sylvia Daunert, Pharm.D., Ph.D. Chair of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine
  • Terry Powley, Ph.D. Distinguished Professor, Purdue University
  • Yvette Tache, Ph.D. Distinguished Research Professor, University of California, Los Angeles
  • Zachary Danziger, Ph.D. Assistant Professor, Florida International University

To receive updates about the Phase 1 winners, subscribe to the Neuromod Prize newsletter.